wehewehe kikoʻī
ʻO Chlamydia pneumoniae (C. pneumoniae) kekahi ʻano bacteria maʻamau a he kumu nui o ka maʻi maʻi maʻi a puni ka honua.Ma kahi o 50% o nā mākua i loaʻa nā hōʻike o ka maʻi i hala ma mua o 20 makahiki, a he mea maʻamau ka maʻi hou ma hope o ke ola.Nui nā haʻawina i manaʻo e pili pono i ka maʻi C. pneumoniae a me nā maʻi ʻeha ʻē aʻe e like me atherosclerosis, exacerbations acute o COPD, a me ka hānō.He mea paʻakikī ka ʻike ʻana i ka maʻi C. pneumoniae ma muli o ke ʻano wikiwiki o ka pathogen, ka nui o ka seroprevalence, a me ka hiki ke loaʻa ke kaʻa asymptomatic transient.Hoʻokumu ʻia nā ʻano hana hoʻokolohua diagnostic e hoʻokaʻawale i ke kino i ka moʻomeheu cell, serological assays a me PCR.ʻO ka ho'āʻo Microimmunofluorescence (MIF), ʻo ia ka "standard gula" i kēia manawa no ka maʻi serological, akā ʻaʻole mau ka hoʻohālikelike ʻana a he paʻakikī ʻenehana.ʻO nā antibody immunoassays nā hoʻokolohua serology maʻamau i hoʻohana ʻia a ʻike ʻia ka maʻi chlamydial mua e ka pane IgM nui i loko o 2 a 4 mau pule a me kahi pane IgG a me IgA lohi i loko o 6 a 8 mau pule.Eia nō naʻe, i ka hoʻomaʻamaʻa hou ʻana, piʻi koke nā pae IgG a me IgA, pinepine i loko o 1-2 pule akā ʻaʻole hiki ke ʻike ʻia nā pae IgM.No kēia kumu, ua hōʻike ʻia nā antibodies IgA he hōʻailona immunological hilinaʻi o nā maʻi mua, maʻi mau a me nā maʻi hou i ka wā i hui pū ʻia me ka ʻike ʻana o IgM.